Newly Diagnosed Glomerulonephritis During COVID-19 Infection Undergoing Immunosuppression Therapy, a Case Report

Authors

  • Firouzeh Moeinzadeh Nephrology Department, Isfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran Author
  • Majid Dezfouli Department of Internal Medicine, Isfahan University of Medical Sciences, Isfahan, Iran Author
  • Azar Naimi Department of Pathology, Isfahan University of Medical Sciences, Isfahan, Iran Author
  • Shahrzad Shahidi Nephrology Department, Isfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran Author
  • Hazhir Moradi Medical School, Isfahan University of Medical Sciences, Isfahan, Iran Author

Abstract

During the COVID-19 pandemic, we had a 25 years old male case without any underlying disease or history of autoimmune disease in COVID-19 Clinic, Isfahan, Iran. He presented with arthralgia and weakness so we started COVID-19 therapeutic regimen. In his hospitalization, creatinine increases and abnormalities in random urine sediment was seen. Methylprednisolone and cyclophosphamide were prescribed due to suspected glomerulonephritis. After renal biopsy the diagnose was confirmed as crescentic proliferative glomerulonephritis. The patient also, underwent plasmapheresis and intravenous immunoglobulin injection. He was discharged healthy without development of new pulmonary symptoms despite immunosuppressive treatment.

Downloads

Download data is not yet available.

Downloads

Published

2020-05-02

Issue

Section

CASE REPORT | Kidney Diseases

How to Cite

Newly Diagnosed Glomerulonephritis During COVID-19 Infection Undergoing Immunosuppression Therapy, a Case Report. (2020). Iranian Journal of Kidney Diseases, 14(3), 239-242. https://www.ijkd.org/index.php/ijkd/article/view/5537

Most read articles by the same author(s)

1 2 > >>